Evidence map›Paper›PMID 26961950›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Menthol Alone Upregulates Midbrain nAChRs, Alters nAChR Subtype Stoichiometry, Alters Dopamine Neuron Firing Frequency, and Prevents Nicotine Reward.

Brandon J Henderson, Teagan R Wall, Beverley M Henley, Charlene H Kim, Weston A Nichols, Ruin Moaddel, Cheng Xiao, Henry A Lester

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 79 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Synthetic cooling agents enhance nicotine reinforcement and mesolimbic dopamine signaling.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Article
  6. Chemosensory tobacco product toxicology part 2: toxicological testing, assays, and state of the science.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Review
  7. Continuous Nicotine Monitors for Personal Nicotine Pharmacokinetics: A Receptor-Aware Research Agenda.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Chemical Flavorants in Vaping Products Alter Neurobiology in a Sex-Dependent Manner to Promote Vaping-Related Behaviors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  18. Morphine Exposure Reduces Nicotine-Induced Upregulation of Nicotinic Receptors and Decreases Volitional Nicotine Intake in a Mouse Model.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Article
  19. Review
  20. Differences in Cognitive Task Performance, Reinforcement Enhancement, and Nicotine Dependence Between Menthol and Nonmenthol Cigarette Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Brandon J HendersonDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, and.ORCID http://orcid.org/0000-0003-0381-028X
Teagan R WallDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, and.
Beverley M HenleyDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, and.
Charlene H KimDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, and.
Weston A NicholsDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, and.
Ruin MoaddelNational Institute on Aging, Baltimore, Maryland 21224.
Cheng XiaoDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, and.ORCID http://orcid.org/0000-0001-9649-7450
Henry A LesterDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, and Lester@Caltech.edu.ORCID http://orcid.org/0000-0002-5470-5255
California Institute of Technology · USNational Institute on Aging · US

Funding

Project 3 University of Colorado, BoulderU19DA019375 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 2005 to 2014
$8.3M
Alpha4 Nicotinic Receptor in Addiction: Mouse ModelsR01DA017279 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 2004 to 2014
$3.5M
Beta2 nicotine receptor subunits: biomarkers for dependenceR01DA036061 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 2014 to 2018
$2.5M
Tools for inside-out pharmacology: nicotinic agentsR01DA037161 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 2013 to 2016
$1.3M
Characterization of menthol's effect on nicotine reward and nicotinic receptor neurobiologyR00DA040047 · NIDA · MARSHALL UNIVERSITY · PI HENDERSON, BRANDON JARROD · 2017 to 2019
$650k
Menthol as a chaperone for nicotonic receptorsR21DA037743 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 2014 to 2015
$413k
Characterization of menthol's effect on nicotine reinforcement and nicotinic receptor neurobiologyK99DA040047 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HENDERSON, BRANDON JARROD · 2016 to 2016
$151k
Expression and Characterization of alpha6beta2beta3 nicotinic receptorsF32DA033721 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HENDERSON, BRANDON JARROD · 2012 to 2014
$150k
Intramural NIH HHSNIDA NIH HHS DA017279NIDA NIH HHS DA019375NIDA NIH HHS DA033721NIDA NIH HHS DA036061NIDA NIH HHS DA037161NIDA NIH HHS DA037743NIDA NIH HHS F32 DA033721NIDA NIH HHS K99 DA040047NIDA NIH HHS R00 DA040047NIDA NIH HHS R01 DA017279NIDA NIH HHS R01 DA036061NIDA NIH HHS R01 DA037161NIDA NIH HHS R21 DA037743NIDA NIH HHS U19 DA019375
6 · The paper itself

Abstract

Upregulation of β2 subunit-containing (β2*) nicotinic acetylcholine receptors (nAChRs) is implicated in several aspects of nicotine addiction, and menthol cigarette smokers tend to upregulate β2* nAChRs more than nonmenthol cigarette smokers. We investigated the effect of long-term menthol alone on midbrain neurons containing nAChRs. In midbrain dopaminergic (DA) neurons from mice containing fluorescent nAChR subunits, menthol alone increased the number of α4 and α6 nAChR subunits, but this upregulation did not occur in midbrain GABAergic neurons. Thus, chronic menthol produces a cell-type-selective upregulation of α4* nAChRs, complementing that of chronic nicotine alone, which upregulates α4 subunit-containing (α4*) nAChRs in GABAergic but not DA neurons. In mouse brain slices and cultured midbrain neurons, menthol reduced DA neuron firing frequency and altered DA neuron excitability following nAChR activation. Furthermore, menthol exposure before nicotine abolished nicotine reward-related behavior in mice. In neuroblastoma cells transfected with fluorescent nAChR subunits, exposure to 500 nm menthol alone also increased nAChR number and favored the formation of (α4)3(β2)2 nAChRs; this contrasts with the action of nicotine itself, which favors (α4)2(β2)3 nAChRs. Menthol alone also increases the number of α6β2 receptors that exclude the β3 subunit. Thus, menthol stabilizes lower-sensitivity α4* and α6 subunit-containing nAChRs, possibly by acting as a chemical chaperone. The abolition of nicotine reward-related behavior may be mediated through menthol's ability to stabilize lower-sensitivity nAChRs and alter DA neuron excitability. We conclude that menthol is more than a tobacco flavorant: administered alone chronically, it alters midbrain DA neurons of the nicotine reward-related pathway.

Indexed as

RewardAcetylcholineAction PotentialsAnimalsCell Line, TumorCells, CulturedConditioning, OperantDopaminergic NeuronsExocytosisLuminescent ProteinsMentholMesencephalonMiceMice, Inbred C57BLMice, TransgenicNeuroblastomaAcetylcholineLuminescent ProteinsMentholNicotineNicotinic AgonistsProtein SubunitsReceptors, Nicotinicdopamine neuronelectrophysiologymentholnicotinenicotinic receptorreward

Identifiers

PMID26961950
PMCPMC4783498
OpenAlexW2294853125

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.